Hepatitis B virus HBx protein interactions with the ubiquitin proteasome system

Viruses

Volumn 6, Issue 11, 2014, Pages 4683-4702

  Minor, Marissa M ^a   Slagle, Betty L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

CSN; DDB1; HBx; Hepatitis B virus; Proteasome; Ubiquitin

Indexed keywords

26S PROTEASOME; BORTEZOMIB; COP9 SIGNALOSOME; CULLIN; CULLIN 4A; CULLIN RING LIGASE; CYSTEINE; DAMAGED DNA BINDING PROTEIN 1; DNA BINDING PROTEIN; HEPATITIS B VIRUS X PROTEIN; LIGASE; MESSENGER RNA; NEDD8 PROTEIN; PROTEASOME; PROTEASOME SUBUNIT ALPHA TYPE 7; REGULATOR PROTEIN; UBIQUITIN; UBIQUITIN CONJUGATING ENZYME E2; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VIRUS DNA; CUL4A PROTEIN, HUMAN; DDB1 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

APOPTOSIS; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; DNA REPAIR; DNA RESPONSIVE ELEMENT; ENHANCER REGION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INNATE IMMUNITY; LIFE CYCLE; MANTLE CELL LYMPHOMA; MULTIPLE MYELOMA; NEOPLASM; NONHUMAN; OPEN READING FRAME; POINT MUTATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION; VIRUS GENOME; VIRUS REPLICATION; HOST PATHOGEN INTERACTION; METABOLISM; PHYSIOLOGY; PROTEIN PROTEIN INTERACTION;

HEPATITIS B VIRUS;

CULLIN PROTEINS; DNA-BINDING PROTEINS; HEPATITIS B VIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN INTERACTION MAPS; TRANS-ACTIVATORS; UBIQUITIN; VIRUS REPLICATION;

EID: 84912568177     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v6114683     Document Type: Review

References (116)

1. Pickart, C.M. Back to the future with ubiquitin. Cell 2004, 116, 181-190.
2. Voutsadakis, I.A. Ubiquitin, ubiquitination and the ubiquitin-proteasome system in cancer. Atlas Genet. Cytogenet. Oncol. Haematol. 2010, 14, 1088-1099.
3. Brooks, P.; Fuertes, G.; Murray, R.Z.; Bose, S.; Knecht, E.; Rechsteiner, M.C.; Hendil, K.B.; Tanaka, K.; Dyson, J.; Rivett, J. Subcellular localization of proteasomes and their regulatory complexes in mammalian cells. Biochem. J. 2000, 346, 155-161.
4. Petroski, M.D.; Deshaies, R.J. Function and regulation of Cullin-RING ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 2005, 6, 9-20.
5. Gustin, J.K.; Moses, A.V.; Fruh, K.; Douglas, J.L. Viral takeover of the host ubiquitin system. Front. Microbiol. 2011, 2, 161.
6. Barry, M.; Fruh, K. Viral modulators of cullin RING ubiquitin ligases: Culling the host defense. Sci. Stke 2006, 335, 1-5.
7. Gao, G.; Luo, H. The ubiquitin-proteasome pathway in viral infections. Can. J. Physiol. Pharmacol. 2006, 84, 5-14.
8. Randow, F.; Lehner, P.J. Viral avoidance and exploitation of the ubiquitin system. Nat. Cell Biol. 2009, 11, 527-534.
9. Choi, A.G.; Wong, J.; Marchant, D.; Luo, H. The ubiquitin-proteasome system in positive-strand RNA virus infection. Rev. Med. Virol. 2013, 23, 85-96.
10. Seeger, C.; Zoulim, F.; Mason, W.S. Hepadnaviruses. In Fields Virology, 6th ed.; Knipe, D.M., Howley, P.M., Eds.; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2013; Volume 1, pp. 2185-2221.
11. Hodgson, A.J.; Slagle, B.L. Molecular biology of HBV-related hepatocellular carcinoma. In Chronic Hepatitis B and C; Shih, C., Ed.; World Scientific Publishing Co. Pte. Ltd.: Singapore, Singapore, 2012; pp. 99-131.
12. Bosu, D.R.; Kipreos, E.T. Cullin-RING ubiquitin ligases: Global regulation and activation cycles. Cell Div. 2008, 3, 7.
13. Metzger, M.B.; Hristova, V.A.; Weissman, A.M. HECT and RING finger families of E3 ubiquitin ligases at a glance. J. Cell Sci. 2012, 125, 531-537.
14. Sarikas, A.; Hartmann, T.; Pan, Z.Q. The cullin protein family. Genome Biol. 2011, 12, 220.
15. Sharma, P.; Nag, A. CUL4A ubiquitin ligase: A promising drug target for cancer and other human diseases. Open Biol. 2014, 4, 130217.
16. Iovine, B.; Iannella, M.L.; Bevilacqua, M.A. Damage-specific DNA binding protein 1 (DDB1): A protein with a wide range of functions. Int. J. Biochem. Cell Biol. 2011, 43, 1664-1667.
17. Jackson, S.; Xiong, Y. CRL4s: The CUL4-RING E3 ubiquitin ligases. Trends Biochem. Sci. 2009, 34, 562-570.
18. Angers, S.; Li, T.; Yi, X.; MacCoss, M.J.; Moon, R.T.; Zheng, N. Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery. Nature 2006, 443, 590-593.
19. He, Y.J.; McCall, C.M.; Hu, J.; Zeng, Y.; Xiong, Y. DDB1 functions as a linker to recruit receptor WD40 proteins to CUL4-ROC1 ubiquitin ligases. Genes Dev. 2006, 20, 2949-2954.
20. Higa, L.A.; Wu, M.; Ye, T.; Kobayashi, R.; Sun, H.; Zhang, H. CUL4-DDB1 ubiquitin ligase interacts with multiple WD40-repeat proteins and regulates histone methylation. Nat. Cell Biol. 2006, 8, 1277-1283.
21. Lee, J.; Zhou, P. DCAFs, the missing link of the CUL4-DDB1 Ubiquitin Ligase. Mol. Cell 2007, 26, 775-780.
22. Kalra, N.; Kumar, V. The X protein of hepatitis B virus binds to the F box protein Skp2 and inhibits the ubiquitination and proteasomal degradation of c-Myc. FEBS Lett. 2006, 580, 431-436.
23. Hori, T.; Osaka, F.; Chiba, T.; Miyamoto, C.; Okabayashi, K.; Shimbara, N.; Kato, S.; Tanaka, K. Covalent modification of all members of human cullin family proteins by NEDD8. Oncogene 1999, 18, 6829-6834.
24. Rabut, G.; Peter, M. Function and regulation of protein neddylation. "Protein modifications: Beyond the usual suspects" review series. EMBO Rep. 2008, 9, 969-976.
25. Higa, L.A.; Banks, D.; Min, W.; Kobayashi, R.; Hong, S.; Hui, Z. L2DTL/CDT2 interacts with the CUL4/DDB1 complex and PCNA and regulates CDT1 proteolysis in response to DNA damage. Cell Cycle 2006, 5, 1675-1680.
26. Colantoni, A.; Bianchi, V.; Gherardini, P.F.; Tomba, G.S.; Ausiello, G.; Helmer-Citterich, M.; Ferre, F. Alternative splicing tends to avoid partial removals of protein-protein interaction sites. BMC Genomics 2013, 14, 379.
27. Hu, J.; McCall, C.M.; Ohta, T.; Xiong, Y. Targeted ubiquitination of CDT1 by the DDB1-CUL4A-ROC1 ligase in response to DNA damage. Nat. Cell Biol. 2004, 6, 1003.
28. Adams, J. The proteasome: A suitable antineoplastic target. Nat. Rev. Cancer 2004, 4, 349-360.
29. Saeki, Y.; Tanaka, K. Assembly and function of the proteasome. Methods Mol. Biol 2012, 832, 315-337.
30. Kniepert, A.; Groettrup, M. The unique functions of tissue-specific proteasomes. Trends Biochem. Sci. 2014, 39, 17-24.
31. Yasui, K.; Arii, S.; Zhao, C.; Imoto, I.; Ueda, M.; Nagai, H.; Emi, M.; Inazawa, J. TFDP1, Cul4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas. Hepatology 2002, 35, 1476-1484.
32. Schindl, M.; Gnant, M.; Schoppmann, S.F.; Horvat, R.; Birner, P. Overexpression of the human homologue for Caenorhabditis elegans cul-4 gene is associated with poor outcome in node-negative breast cancer. Anticancer Res. 2007, 27, 949-952.
33. Birner, P.; Schoppmann, A.; Schindl, M.; Dinhof, C.; Jesch, B.; Berghoff, A.S.; Schoppmann, S.F. Human homologue for Caenorhabditis elegans CUL-4 protein overexpression is associated with malignant potential of epithelial ovarian tumours and poor outcome in carcinoma. J. Clin. Pathol. 2012, 65, 507-511.
34. Kane, R.C.; Bross, P.F.; Farrell, A.T.; Pazdur, R. Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy. Oncologist 2003, 8, 508-513.
35. Kane, R.C.; Dagher, R.; Farrell, A.; Ko, C.W.; Sridhara, R.; Justice, R.; Pazdur, R. Bortezomib for the treatment of mantle cell lymphoma. Clin. Cancer Res. 2007, 13, 5291-5294.
36. Rehermann, B.; Nascimbeni, M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 2005, 5, 215-229.
37. Dandri, M.; Locarnini, S. New insight in the pathobiology of hepatitis B virus infection. Gut 2012, 61 (Suppl. 1), i6-i17.
38. Yan, H.; Zhong, G.; Xu, G.; He, W.; Jing, Z.; Gao, Z.; Huang, Y.; Qi, Y.; Peng, B.; Wang, H.; et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife 2012, 1, e00049.
39. Zhong, G.; Yan, H.; Wang, H.; He, W.; Jing, Z.; Qi, Y.; Fu, L.; Gao, Z.; Huang, Y.; Xu, G.; et al. Sodium taurocholate cotransporting polypeptide mediates woolly monkey hepatitis B virus infection of Tupaia hepatocytes. J. Virol. 2013, 87, 7176-7184.
40. Ni, Y.; Lempp, F.A.; Mehrle, S.; Nkongolo, S.; Kaufman, C.; Falth, M.; Stindt, J.; Koniger, C.; Nassal, M.; Kubitz, R.; et al. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes. Gastroenterology 2013, 146, 1070-1083.
41. Funk, A.; Mhamdi, M.; Will, H.; Sirma, H. Avian hepatitis B viruses: Molecular and cellular biology, phylogenesis, and host tropism. World J. Gastroenterol. 2007, 13, 91-103.
42. Tennant, B.C.; Toshkov, I.A.; Peek, S.F.; Jacob, J.R.; Menne, S.; Hornbuckle, W.E.; Schinazi, R.D.; Korba, B.E.; Cote, P.J.; Gerin, J.L. Hepatocellular carcinoma in the woodchuck model of hepatitis B virus infection. Gastroenterology 2004, 127, S283-S293.
43. Chen, H.-S.; Kaneko, S.; Girones, R.; Anderson, R.W.; Hornbuckle, W.E.; Tennant, B.C.; Cote, P.J.; Gerin, J.L.; Purcell, R.H.; Miller, R.H. The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J. Virol. 1993, 67, 1218-1226.
44. Zoulim, F.; Saputelli, J.; Seeger, C. Woodchuck hepatitis virus X protein is required for viral infection in vivo. J. Virol. 1994, 68, 2026-2030.
45. Scaglioni, P.P.; Melegari, M.; Wands, J.R. Posttranscriptional regulation of hepatitis B virus replication by the precore protein. J. Virol. 1997, 71, 345-353.
46. Tsuge, M.; Hiraga, N.; Akiyama, R.; Tanaka, S.; Matsushita, M.; Mitsui, F.; Abe, H.; Kitamura, S.; Hatakeyama, T.; Kimura, T.; et al. HBx protein is indispensable for development of viraemia in human hepatocyte chimeric mice. J. Gen. Virol. 2010, 91, 1854-1864.
47. Melegari, M.; Scaglioni, P.P.; Wands, J.R. Cloning and characterization of a novel hepatitis B virus X binding protein that inhibits viral replication. J. Virol. 1998, 72, 1737-1743.
48. Bouchard, M.J.; Wang, L.-H.; Schneider, R.J. Calcium signaling by HBx protein in hepatitis B virus DNA replication. Science 2002, 294, 2376-2378.
49. Hoare, J.; Henkler, F.; Dowling, J.J.; Errington, W.; Goldin, R.D.; Fish, D.; McGarvey, M.J. Subcellular localization of the X protein in HBV infected hepatocytes. J. Med. Virol. 2001, 64, 419-426.
50. Cha, M.Y.; Ryu, D.K.; Jung, H.S.; Chang, H.E.; Ryu, W.S. Stimulation of hepatitis B virus genome replication by HBx is linked to both nuclear and cytoplasmic HBx expression. J. Gen. Virol. 2006, 90, 978-986.
51. Henkler, F.; Hoare, J.; Waseem, N.; Goldin, R.D.; McGarvey, M.J.; Koshy, R.; King, I.A. Intracellular localization of the hepatitis B virus HBx protein. J. Gen. Virol 2001, 82, 871-882.
52. Tang, H.; Oishi, N.; Kaneko, S.; Murakami, S. Molecular functions and biological roles of hepatitis B virus X protein. Cancer Sci. 2006, 97, 977-983.
53. Bouchard, M.J.; Schneider, R.J. The enigmatic X gene of hepatitis B virus. J. Virol. 2004, 78, 12725-12734.
54. Feitelson, M.A.; Duan, L.-X. Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma. Am. J. Pathol. 1997, 150, 1141-1157.
55. Cougot, D.; Neuveut, C.; Buendia, M.A. HBV induced carcinogenesis. J. Clin. Virol. 2005, 34 (Suppl. 1), S75-S78.
56. Fallot, G.; Neuveut, C.; Buendia, M.A. Diverse roles of hepatitis B virus in liver cancer. Curr. Opin. Virol. 2012, 2, 467-473.
57. Benhenda, S.; Cougot, D.; Buendia, M.A.; Neuveut, C. Hepatitis B virus X protein molecular functions and its role in virus life cycle and pathogenesis. Adv. Cancer Res. 2009, 103, 75-109.
58. Wei, Y.; Neuveut, C.; Tiollais, P.; Buendia, M.A. Molecular biology of the hepatitis B virus and role of the X gene. Pathol. Biol. Paris 2010, 58, 267-272.
59. Lucifora, J.; Protzer, U. Hepatitis B virus X protein: A key regulator of the virus life cycle. In Viral Genomes-Molecular Structure, Diversity, Gene Expression Mechanisms and Host-Virus Interactions; Garcia, M.L., Romanowski, V., Eds.; InTech: Rijeka, Croatia, 2012; pp. 141-154.
60. Seeger, C.; Zoulim, F.; Mason, W.S. Hepadnaviruses. In Fields Virology, 5th ed.; Knipe, D.M., Griffin, D.E., Lamb, R.A., Strauss, S.E., Howley, P.M., Martin, M.A., Roizman, B., Eds.; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2007; Volume 2, pp. 2977-3029.
61. Du, J.; Zhou, Y.; Fu, Q.X.; Gong, W.L.; Zhao, F.; Peng, J.C.; Zhan, L.S. Bioluminescence imaging of hepatitis B virus enhancer and promoter activities in mice. FEBS Lett. 2008, 582, 3552-3556.
62. Kumar, V.; Sarkar, D.P. Hepatitis B virus X protein: Structure-Function relationships and role in viral pathogenesis. In Transcription Factors; Gossen, M., Kaufmann, J., Triezenberg, S.J., Eds.; Springer-Verlag: Berlin Heidelberg, Germany, 2004; pp. 377-407.
63. Miseta, A.; Csutora, P. Relationship between the occurrence of cysteine in proteins and the complexity of organisms. Mol. Biol. Evol. 2000, 17, 1232-1239.
64. Gupta, A.; Mal, T.K.; Jayasuryan, N.; Chauhan, V.S. Assignment of disulphide bonds in the X protein (HBx) of hepatitis B virus. Biochem. Biophys. Res. Commun. 1995, 212, 919-924.
65. Sidhu, K.; Kumar, S.; Reddy, V.S.; Kumar, V. Mass spectrometric determination of disulfide bonds in the biologically active recombinant HBx protein of hepatitis B virus. Biochemistry 2014, 53, 4685-4695.
66. Leon, D.A.; Herberg, F.W.; Banky, P.; Taylor, S.S. A stable alpha-helical domain at the N terminus of the RIalpha subunits of cAMP-dependent protein kinase is a novel dimerization/docking motif. J. Biol. Chem. 1997, 272, 28431-28437.
67. Locker, J.K.; Griffiths, G. An unconventional role for cytoplasmic disulfide bonds in vaccinia virus proteins. J. Cell Biol. 1999, 144, 267-279.
68. Saaranen, M.J.; Ruddock, L.W. Disulfide bond formation in the cytoplasm. Antioxid. Redox. Signal. 2013, 19, 46-53.
69. Zhang, Z.; Torii, N.; Furusaka, A.; Malayaman, N.; Hu, Z.Y.; Liang, T.J. Structural and functional characterization of interaction between hepatitis B virus X protein and the proteasome complex. J. Biol. Chem. 2000, 275, 15157-15165.
70. Kidd-Ljunggren, K.; Oberg, M.; Kidd, A.H. The hepatitis B virus X gene: Analysis of functional domain variation and gene phylogeny using multiple sequences. J. Gen. Virol. 1995, 76, 2119-2130.
71. Kim, J.H.; Sohn, S.Y.; Yen, T.S.B.; Ahn, B.Y. Ubiquitin-dependent and -independent proteasomal degradation of hepatitis B virus X protein. Biochem. Biophys. Res. Commun. 2008, 366, 1036-1042.
72. Lucifora, J.; Arzberger, S.; Durantel, D.; Belloni, L.; Strubin, M.; Levrero, M.; Zoulim, F.; Hantz, O.; Protzer, U. Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection. J. Hepatol. 2011, 55, 996-1003.
73. Slagle, B.L.; Andrisani, O.M.; Bouchard, M.J.; Lee, C.G.; Ou, J.H.; Siddiqui, A. Technical standards for hepatitis B virus X protein (HBx) research. Hepatology 2014, doi:10.1002/hep.27360.
74. Zhang, Z.-S.; Torii, N.; Hu, Z.; Jacob, J.; Liang, T.J. X-deficient woodchuck hepatitis virus mutants behave like attenuated viruses and induce protective immunity in vivo. J. Clin. Investig. 2001, 108, 1523-1531.
75. Urban, S.; Hildt, E.; Eckerskorn, C.; Sirma, H.; Kekule, A.; Hofschneider, P.H. Isolation and molecular characterization of hepatitis B virus X-protein from a baculovirus expression system. Hepatology 1997, 26, 1045-1053.
76. Song, C.Z.; Bai, Z.L.; Song, C.C.; Wang, Q.W. Aggregate formation of hepatitis B virus X protein affects cell cycle and apoptosis. World J. Gastroenterol. 2003, 9, 1521-1524.
77. Lee, T.-H.; Elledge, S.J.; Butel, J.S. Hepatitis B virus X protein interacts with a probable cellular DNA repair protein. J. Virol. 1995, 69, 1107-1114.
78. Keasler, V.V.; Slagle, B.L. The interaction of HBx with cellular DDB1. In The Pleiotropic Functions of the Viral Protein HBx in Hepatitis B Virus Infection and the Development of Liver Cancer; Kobarg, J., Ed.; Research Signpost: Kerala, India, 2008; pp. 91-103.
79. Li, T.; Robert, E.I.; van Breugel, P.C.; Strubin, M.; Zheng, N. A promiscuous alpha-helical motif anchors viral hijackers and substrate receptors to the CUL4-DDB1 ubiquitin ligase machinery. Nat. Struct. Mol. Biol. 2010, 17, 105-111.
80. Rho, H.M.; Choi, C.Y.; Choi, B.H.; Paik, N.W. The interference of HBx in transcriptional regulation. In The Pleiotropic Functions of the Viral Protein HBx in Hepatitis B Virus Infection and the Development of Liver Cancer; Kobarg, J., Ed.; Research Signpost: Kerala, India, 2008; pp. 11-41.
81. Hodgson, A.J.; Hyser, J.M.; Keasler, V.V.; Cang, Y.; Slagle, B.L. Hepatitis B virus regulatory HBx protein binding to DDB1 is required but is not sufficient for maximal HBV replication. Virology 2012, 426, 73-82.
82. Sitterlin, D.; Lee, T.H.; Prigent, S.; Tiollais, P.; Butel, J.S.; Transy, C. Interaction of the UV-damaged DNA-binding protein with hepatitis B virus X protein is conserved among mammalian hepadnaviruses and restricted to transactivation-proficient X-insertion mutants. J. Virol. 1997, 71, 6194-6199.
83. Sitterlin, D.; Bergametti, F.; Tiollais, P.; Tennant, B.C.; Transy, C. Correct binding of viral X protein to UVDDB-p127 cellular protein is critical for efficient infection by hepatitis B viruses. Oncogene 2000, 19, 4427-4431.
84. Leupin, O.; Bontron, S.; Schaeffer, C.; Strubin, M. Hepatitis B virus X protein stimulates viral genome replication via a DDB1-dependent pathway distinct from that leading to cell death. J. Virol. 2005, 79, 4238-4245.
85. Bontron, S.; Lin-Marq, N.; Strubin, M. Hepatitis B virus X protein associated with UV-DDB1 induces cell death in the nucleus and is functionally antagonized by UV-DDB2. J. Biol. Chem. 2002, 277, 38847-38854.
86. Zhang, S.M.; Sun, D.C.; Lou, S.; Bo, X.C.; Lu, Z.; Qian, X.H.; Wang, S.Q. HBx protein of hepatitis B virus (HBV) can form complex with mitochondrial HSP60 and HSP70. Arch. Virol. 2005, 150, 1579-1590.
87. Tanaka, Y.; Kanai, F.; Ichimura, T.; Tateishi, K.; Asaoka, Y.; Guleng, B.; Jazag, A.; Ohta, M.; Imamura, J.; Ikenoue, T.; et al. The hepatitis B virus X protein enhances AP-1 activation through interaction with Jab1. Oncogene 2006, 25, 633-642.
88. Gastaldello, S.; Hildebrand, S.; Faridani, O.; Callegari, S.; Palmkvist, M.; Di, G.C.; Masucci, M.G. A deneddylase encoded by Epstein-Barr virus promotes viral DNA replication by regulating the activity of cullin-RING ligases. Nat. Cell Biol. 2010, 12, 351-361.
89. Huang, J.; Kwong, J.; Sun, E.C.Y.; Liang, T.J. Proteasome complex as a potential cellular target of hepatitis B virus X protein. J. Virol. 1996, 70, 5582-5591.
90. Hu, Z.Y.; Zhang, Z.S.; Doo, E.; Coux, O.; Goldberg, A.L.; Liang, T.J. Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex. J. Virol. 1999, 73, 7231-7240.
91. Zhang, Z.; Sun, E.; Ou, J.H.; Liang, T.J. Inhibition of cellular proteasome activities mediates HBX-independent hepatitis B virus replication in vivo. J. Virol. 2010, 84, 9326-9331.
92. Bandi, P.; Garcia, M.L.; Booth, C.J.; Chisari, F.V.; Robek, M.D. Bortezomib inhibits hepatitis B virus replication in transgenic mice. Antimicrob. Agents Chemother. 2010, 54, 749-756.
93. Lee, J.; Zhou, P. Pathogenic role of the CRL4 ubiquitin ligase in human disease. Front. Oncol. 2012, 2, 21.
94. Stohwasser, R.; Holzhutter, H.G.; Lehmann, U.; Henklein, P.; Kloetzel, P.M. Hepatitis B virus HBx peptide 116-138 and proteasome activator PA28 compete for binding to the proteasome alpha4/MC6 subunit. Biol. Chem. 2003, 384, 39-49.
95. Lin, G.Y.; Paterson, R.G.; Richardson, C.D.; Lamb, R.A. The V protein of Paramyxovirus SV5 interacts with damage-specific DNA binding protein. Virology 1998, 249, 189-200.
96. Ulane, C.M.; Horvath, C.M. Paramyxoviruses SV5 and HPIV2 assemble STAT protein ubiquitin ligase complexes from cellular components. Virology 2002, 304, 160-166.
97. Precious, B.; Childs, K.; Fitzpatrick-Swallow, V.; Goodbourn, S.; Randall, R.E. Simian virus 5 V protein acts as an adaptor, linking DDB1 to STAT2, to facilitate the ubiquitination of STAT1. J. Virol. 2005, 79, 13434-13441.
98. Horvath, C.M. Weapons of STAT destruction. Interferon evasion by paramyxovirus V protein. Eur. J. Biochem. 2004, 271, 4621-4628.
99. Ahn, J.; Hao, C.; Yan, J.; DeLucia, M.; Mehrens, J.; Wang, C.; Gronenborn, A.M.; Skowronski, J. HIV/simian immunodeficiency virus (SIV) accessory virulence factor Vpx loads the host cell restriction factor SAMHD1 onto the E3 ubiquitin ligase complex CRL4DCAF1. J. Biol. Chem. 2012, 287, 12550-12558.
100. Wieland, S.F.; Chisari, F.V. Stealth and cunning: Hepatitis B and hepatitis C viruses. J. Virol. 2005, 79, 9369-9380.
101. Wei, C.; Ni, C.; Song, T.; Liu, Y.; Yang, X.; Zheng, Z.; Jia, Y.; Yuan, Y.; Guan, K.; Xu, Y.; et al. The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein. J. Immunol. 2010, 185, 1158-1168.
102. Kumar, M.; Jung, S.Y.; Hodgson, A.J.; Madden, C.R.; Qin, J.; Slagle, B.L. Hepatitis B virus regulatory HBx protein binds to adaptor protein IPS-1 and inhibits the activation of beta interferon. J. Virol. 2011, 85, 987-995.
103. Jiang, J.; Tang, H. Mechanism of inhibiting type I interferon induction by hepatitis B virus X protein. Protein Cell 2011, 1, 1106-1117.
104. Ulane, C.M.; Rodriguez, J.J.; Parisien, J.P.; Horvath, C.M. STAT3 ubiquitylation and degradation by mumps virus suppress cytokine and oncogene signaling. J. Virol. 2003, 77, 6385-6393.
105. Le Rouzic, E.; Belaidouni, N.; Estrabaud, E.; Morel, M.; Rain, J.C.; Transy, C.; Margottin-Goguet, F. HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the CUL4-DDB1 ubiquitin ligase. Cell Cycle 2007, 6, 182-188.
106. Schrofelbauer, B.; Hakata, Y.; Landau, N.R. HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1. Proc. Natl. Acad. Sci. USA 2007, 104, 4130-4135.
107. Srivastava, S.; Swanson, S.K.; Manel, N.; Florens, L.; Washburn, M.P.; Skowronski, J. Lentiviral Vpx accessory factor targets VprBP/DCAF1 substrate adaptor for cullin 4 E3 ubiquitin ligase to enable macrophage infection. PLoS Pathog. 2008, 4, e1000059.
108. Liang, X.Z.; Pickering, M.T.; Cho, N.H.; Chang, H.; Volkert, M.R.; Kowalik, T.F.; Jung, J.U. Deregulation of DNA damage signal transduction by herpesvirus latency-associated M2. J. Virol. 2006, 80, 5862-5874.
109. Gearhart, T.L.; Bouchard, M.J. Replication of the hepatitis B virus requires a calcium-dependent HBx-induced G1 phase arrest of hepatocytes. Virology 2010, 407, 14-25.
110. Casciano, J.C.; Bagga, S.; Yang, B.; Bouchard, M.J. Modulation of cell proliferation pathways by the hepatitis B virus X protein: A potential contributor to the development of hepatocellular carcinoma. In Hepatocellular Carcinoma-Basic Research; Lau, W.Y., Ed.; InTech: Rijeka, Croatia, 2012; pp. 103-152.
111. Wang, W.H.; Hullinger, R.L.; Andrisani, O.M. Hepatitis B virus X protein via the p38MAPK pathway induces E2F1 release and ATR kinase activation mediating p53 apoptosis. J. Biol. Chem. 2008, 283, 25455-25467.
112. Studach, L.; Wang, W.H.; Weber, G.; Tang, J.; Hullinger, R.L.; Malbrue, R.; Liu, X.; Andrisani, O. Polo-like kinase 1 activated by the hepatitis B virus X protein attenuates both the DNA damage checkpoint and DNA repair resulting in partial polyploidy. J. Biol. Chem. 2010, 285, 30282-30293.
113. Rakotomalala, L.; Studach, L.; Wang, W.H.; Gregori, G.; Hullinger, R.L.; Andrisani, O. Hepatitis B virus X protein increases the Cdt1-to-geminin ratio inducing DNA re-replication and polyploidy. J. Biol. Chem. 2008, 283, 28729-28740.
114. Becker, S.A.; Lee, T.H.; Butel, J.S.; Slagle, B.L. Hepatitis B virus X protein interferes with cellular DNA repair. J. Virol. 1998, 72, 266-272.
115. Qadri, I.; Fatima, K.; AbdeL-Hafiz, H. Hepatitis B virus X protein impedes the DNA repair via its association with transcription factor, TFIIH. BMC Microbiol. 2011, 11, 48-62.
116. Warmerdam, D.O.; Kanaar, R. Dealing with DNA damage: Relationships between checkpoint and repair pathways. Mutat. Res. 2010, 704, 2-11.